UBS Group’s NEOS Enhanced Income 1-3 Month T-Bill ETF CSHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8M Buy
160,683
+160,677
+2,677,950% +$7.98M ﹤0.01% 3590
2025
Q4
$298 Buy
+6
New +$299 ﹤0.01% 10050
2025
Q3
Sell
-1,672
Closed -$83.1K 10399
2025
Q2
$83.1K Buy
+1,672
New +$83K ﹤0.01% 7389
2025
Q1
Sell
-111
Closed -$5.53K 10289
2024
Q4
$5.53K Sell
111
-5,547
-98% -$277K ﹤0.01% 8646
2024
Q3
$282K Buy
+5,658
New +$282K ﹤0.01% 5621
2023
Q3
Sell
-316
Closed -$15.8K 9535
2023
Q2
$15.8K Buy
+316
New +$15.9K ﹤0.01% 6978
2023
Q1
Sell
-563
Closed -$28.1K 9698
2022
Q4
$28.1K Buy
+563
New +$28.2K ﹤0.01% 7304

Other funds holding CSHI

UBS Group's CSHI Position: Q1 2026 in Review

UBS Group increased its NEOS Enhanced Income 1-3 Month T-Bill ETF (CSHI) stake by 2,677,950% in Q1 2026, buying an estimated $7.98M and bringing the position to 160,683 shares worth $8M. The position accounts for ﹤0.01% of the portfolio, ranked #3590.

UBS Group first reported a position in CSHI in Q4 2022 and has held it in 7 quarters since. 116 funds tracked by Wall St. Rank hold CSHI as of Q1 2026.

  • UBS Group held 160,683 shares of NEOS Enhanced Income 1-3 Month T-Bill ETF worth $8M as of Q1 2026.
  • UBS Group bought 160,677 NEOS Enhanced Income 1-3 Month T-Bill ETF shares in Q1 2026, an estimated $7.98M.
  • NEOS Enhanced Income 1-3 Month T-Bill ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3590 holding.
  • UBS Group first reported a position in NEOS Enhanced Income 1-3 Month T-Bill ETF in Q4 2022 and has held it in 7 quarters since.
  • 116 funds tracked by Wall St. Rank held NEOS Enhanced Income 1-3 Month T-Bill ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.